Quantum Stocks Slump Deepens as IonQ Touches New Low Following US Executive Orders

The sell-off in quantum computing shares has intensified, with IonQ falling to a fresh 2026 low on July 16 as the sector continues to digest the implications of two far-reaching executive orders signed by President Trump last month. The stock closed at $35.025, down 6.6% on the day after briefly dipping to $34.67, and has shed roughly 37% over the past 30 days. The relative strength index has sunk to 26.1, firmly in oversold territory, signaling how rapidly investor sentiment has soured on the quantum computing specialist.

The broader context for the rout lies in the regulatory landscape. On June 22, the White House launched the QC-ADDS initiative, setting a 2028 target for a fully functional quantum computer, while simultaneously mandating a migration to post-quantum cryptography with deadlines in 2030 and 2031 — a response to the threat of ‘harvest now, decrypt later’ attacks. According to multiple reports, quantum equities have fallen about 35% from the peaks they reached immediately after those announcements. IonQ’s own trajectory illustrates the decline: from a high above $60 earlier in the year to roughly $39 on July 13, followed by an additional 8% drop on July 16. The pain is sector-wide — Rigetti Computing has lost 29% and D-Wave Quantum 27.8% over the same 30-day window — but IonQ has been the hardest hit.

Compounding the regulatory headwind, the distribution of $2.013 billion in CHIPS Act funding to nine quantum firms on May 21 has recalibrated investor expectations. IBM received the largest single allocation — $1 billion for a chip foundry in Albany — signaling that government support is spreading broadly rather than concentrating on a few perceived leaders. That shift in funding architecture has prompted a more selective approach to valuations, dampening the earlier euphoria that had lifted stocks across the quantum universe.

Should investors sell immediately? Or is it worth buying IonQ?

Amid this sector turbulence, IonQ’s own financial picture is a study in contrasts. The company smashed revenue estimates for the first quarter, reporting $64.67 million — a 754.7% surge year-over-year and well above the consensus forecast of $49.75 million. Management also raised its full-year revenue guidance by $25 million to a range of $260–$270 million, and noted the first-ever sale of a 256-qubit system. Yet the bottom line disappointed: a GAAP net loss per share of $0.34 versus expectations of a $0.26 loss, reflecting an operating loss of $271.5 million. The headline net gain of $805.4 million was almost entirely due to a non-cash gain on convertible notes. Analysts polled by Zacks now expect a full-year loss of $1.07 per share on revenue of $267.45 million, and the stock currently carries a Zacks Rank #3 (Hold).

Insider activity has added to the negative tone. Over the past three months, company executives sold a total of 13,102 shares valued at $701,489. In June alone, board member John Raymond disposed of 3,815 shares at $55.01 each, and Gabrielle Toledano sold 2,757 shares at the same price — both well above the current market level. On the options market, bearish bets are piling up: some 199,216 put contracts changed hands on July 16, a 130% surge above the average daily volume. Institutional investors including Vanguard and State Street, however, have been adding to their positions during the same period.

Despite the severe correction, the analyst community remains broadly constructive. The consensus rating is ‘Moderate Buy’ with a median price target of $69.88 — nearly double the current share price. That wide gap between market price and analyst expectations captures the tension between near-term regulatory uncertainty and the long-term growth narrative that IonQ continues to articulate through its expanding revenue base and $470 million remaining performance obligations. The next test for the stock will come on August 5, when the company reports second-quarter results. With the sector already under intense scrutiny, any miss on guidance or margins could deepen the downturn, while a beat might begin to close the chasm between price and promise.